Your CSV is on the way
We’ve sent your CSV file to [email protected]
Search Startups
Multiple funding stages Startups
Filters
Clear
3935 Startups
69 In the News
277 Recently Updated
I already have access,
-
Total Funding$112.38BRaised6,194Events
-
Private Funding$50.75BRaised5,186Rounds
-
Public Offerings$0Raised1Offerings
-
M&A$61.62BRaised1,007Deals
Funding
Number of Employees
Rounds / Deals
Funding Stage
Emendo Biotherapeutics
Presumed Inactive
?
Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
EndoGI Medical
Enzymit
Exabeam
Exodigo
ExoProTher Medical
Eyecuracy
Notifications settings
Off
Frequency:
Select all
Search Startups
Funding Amount
Funding Stages
-
Total Funding$112.38BRaised6,194Events
-
Private Funding$50.75BRaised5,186Rounds
-
Public Offerings$0Raised1Offerings
-
M&A$61.62BRaised1,007Deals
Funding
Rounds / Deals
Raised
$73M
Emendo Biotherapeutics
Presumed Inactive
?
Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
DNA Correction and Genome-editing Platforms
Founded:2015
Business Model:B2B
Employees:51-200
Funding Stage:Acquired
Raised
$54.68K
EndoGI Medical
Advanced Gastrointestinal Solutions
Founded:2017
Business Model:B2B
Employees:1-10
Funding Stage:A
Raised
$6.5M
Enzymit
Cell-free Bioproduction
Founded:2020
Business Model:B2B
Employees:11-50
Funding Stage:A
Raised
$390M
Exabeam
Security Operations Platform
Founded:2013
Business Model:B2B
Employees:500+
Funding Stage:F
Raised
$146M
Exodigo
Nonintrusive Subsurface Mapping Solution
Founded:2021
Business Model:B2B, B2G
Employees:51-200
Funding Stage:A
Raised
$5.95M
ExoProTher Medical
Nanoparticle based cancer therapy addressing the most common mutation in cancer - p53 driven mechanism of anti-cancer defense
Founded:2017
Business Model:B2B
Employees:1-10
Funding Stage:Seed
Raised
$1.3M
Eyecuracy
Eyecuracy offers an innovative breakthrough solution for diagnosing, monitoring, and treating neuro-ophthalmological and neurological conditions. In practitioners office and in patient's home.
Founded:2022
Business Model:B2B, B2B2C
Employees:1-10
Funding Stage:Seed
Unlock financial data
Finder is provided for free by the non-profit organization Startup Nation Central.
- Get unlimited search results
- Save to custom lists - Watchlists
- Get notified with news and updates
- Connect with people
And much more...
I already have access,